Key result
Comorbid muscular dystrophy linked to ~3-fold higher inpatient mortality in heart failure hospitalizations.
Why the study?
Outcomes specific to heart failure hospitalizations in patients with muscular dystrophies are poorly characterized.
Does concomitant muscular dystrophy worsen clinical outcomes and increase resource utilization in adult patients hospitalized for heart failure?
Cohort (n=8,466,806)
Yes
Does concomitant muscular dystrophy worsen clinical outcomes and increase resource utilization in adult patients hospitalized for heart failure?
Adults with muscular dystrophy hospitalized for heart failure face a three-fold higher risk of inpatient mortality, more complications, and greater resource utilization compared to heart failure patients without muscular dystrophy.
Answers are grounded in this paper and cite their sources.
May warrant closer inpatient monitoring in HF with muscular dystrophy; leaves open whether targeted strategies improve survival.
Background Muscular dystrophies (MDs) may cause heart failure (HF), but outcomes specific to MD-related HF are poorly characterized. We evaluated outcomes of HF hospitalizations in patients with MDs compared to patients without MD in the United States. Methods Discharge data from HF hospitalizations were abstracted from the Nationwide Readmissions Database (2016–2022) and stratified by the presence or absence of MD (MD-HF vs. non-MD-HF). Logistic regression and lognormal models were estimated to assess differences in inpatient mortality, length of stay (LOS), total costs, in-hospital events, and 30-day and 90-day all-cause readmissions. Propensity-score matching (PSM) was used to control baseline differences between the MD-HF and non-MD-HF cohorts. Results 8,466,806 HF hospitalizations were included in the analysis, of which 3688 (0.04%) involved patients with MD. MD-HF hospitalizations involved younger patients (mean age 55.3 vs. 71.3 years, p < 0.001) with higher rates of HF with reduced ejection fraction (HFrEF) compared to non-MD-HF hospitalizations (48.1% vs. 34.9%, p < 0.001). Compared to non-MD-HF hospitalizations, MD-HF hospitalizations were associated with significantly higher odds of inpatient mortality (OR 3.01, 95% CI: 2.03, 4.45); in-hospital events, including cardiogenic shock, cardiac arrest, and mechanical ventilation; palliative care consultation; as well as more extended hospital LOS, higher total costs, and lower odds of home (all p < 0.001). MD was not associated with a significant difference in odds of 30-day and 90-day all-cause readmissions. Conclusion MD-HF hospitalizations were associated with worse outcomes, with higher inpatient mortality, complication rates, and resource utilization, and a lower rate of home discharge compared to non-MD-HF hospitalizations.
No takes yet. Share an insight, caveat, or question.
Jabbar et al. (2026) conducted a cohort in Heart Failure in Muscular Dystrophy (n=8,466,806). Muscular Dystrophy vs. No Muscular Dystrophy was evaluated on All-cause inpatient mortality (OR 3.01, 95% CI 2.03-4.45, p=<0.001). Comorbid muscular dystrophy in heart failure hospitalizations was associated with a 3-fold higher risk of inpatient mortality compared to patients without muscular dystrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: